Tapewire

Nasdaq · USD

LUNG

Pulmonx Corp

Export transactions ↓
Tapewire entity
2359
SEC CIK
0001127537
Parsed reports
229

Last 12 months

Inside the activity.

0 purchase rows · 55 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025011
Jan 202600
Feb 202600
Mar 2026015
Apr 202600
May 202600
Jun 2026015
Jul 202600
Aug 202600
Sep 2026014
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2022 Filed Jun 3, 2022 21:56 UTC GrantCommon Stock 5,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034286 · doc4.xml · nonDerivative · entry 1

Florin Daniel P · CIK 0001402459 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,132

F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:52 UTC GrantCommon Stock 5,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034280 · doc4.xml · nonDerivative · entry 1

Lynch Alissa Hsu · CIK 0001875681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,210

F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.

Read SEC document
June 01, 2022 Filed Jun 7, 2022 21:44 UTC GrantCommon Stock 5,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034882 · doc4.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,597

F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.

Read SEC document
May 16, 2022 Filed May 18, 2022 22:11 UTC
French Glendon E. IIIDirector · President and CEO
GiftCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-030215 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,107,517

F1 · kind: Represents a charitable donation of the shares of the Issuer made by the Reporting Person.

Read SEC document
March 10, 2022 Filed Mar 11, 2022 23:06 UTC
Rose Geoffrey BeranChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 29,427 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001209191-22-018263 · doc4.xml · derivative · entry 2

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,192

Underlying: Common Stock · 29,427 shares

Expires 2029-10-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on October 2, 2019, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
March 10, 2022 Filed Mar 11, 2022 23:06 UTC
Rose Geoffrey BeranChief Commercial Officer
Exercise / conversionCommon Stock 29,427 $2.10 $61,796.70
Disclosure

SEC source: 0001209191-22-018263 · doc4.xml · nonDerivative · entry 1

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,129

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:13 UTC
Rose Geoffrey BeranChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 68,700 $0.00 Strike: $26.56 $0.00
Disclosure

SEC source: 0001209191-22-015836 · doc4.xml · derivative · entry 3

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,700

Underlying: Common Stock · 68,700 shares

Expires 2032-02-29

F4 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:13 UTC
Rose Geoffrey BeranChief Commercial Officer
GrantCommon Stock 31,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015836 · doc4.xml · nonDerivative · entry 2

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,702

F3 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:13 UTC
Rose Geoffrey BeranChief Commercial Officer
SaleCommon Stock 426 $25.91 $11,037.66
Disclosure

SEC source: 0001209191-22-015836 · doc4.xml · nonDerivative · entry 1

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,702

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2 · balance_after: Includes 669 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:14 UTC
Sung DerrickChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 68,700 $0.00 Strike: $26.56 $0.00
Disclosure

SEC source: 0001209191-22-015840 · doc4.xml · derivative · entry 3

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,700

Underlying: Common Stock · 68,700 shares

Expires 2032-02-29

F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:14 UTC
Sung DerrickChief Financial Officer
GrantCommon Stock 31,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015840 · doc4.xml · nonDerivative · entry 2

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,962

F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:14 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 458 $25.91 $11,866.78
Disclosure

SEC source: 0001209191-22-015840 · doc4.xml · nonDerivative · entry 1

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,962

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:11 UTC
Lehman David AaronGeneral Counsel
GrantEmployee Stock Option (right to buy) · Derivative 68,700 $0.00 Strike: $26.56 $0.00
Disclosure

SEC source: 0001209191-22-015828 · doc4.xml · derivative · entry 3

Lehman David Aaron · CIK 0001354228 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,700

Underlying: Common Stock · 68,700 shares

Expires 2032-02-29

F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:11 UTC
Lehman David AaronGeneral Counsel
GrantCommon Stock 31,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015828 · doc4.xml · nonDerivative · entry 2

Lehman David Aaron · CIK 0001354228 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,376

F2 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:11 UTC
Lehman David AaronGeneral Counsel
SaleCommon Stock 458 $25.91 $11,866.78
Disclosure

SEC source: 0001209191-22-015828 · doc4.xml · nonDerivative · entry 1

Lehman David Aaron · CIK 0001354228 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,376

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:03 UTC
French Glendon E. IIIDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 154,600 $0.00 Strike: $26.56 $0.00
Disclosure

SEC source: 0001209191-22-015792 · doc4.xml · derivative · entry 3

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,600

Underlying: Common Stock · 154,600 shares

Expires 2032-02-29

F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:03 UTC
French Glendon E. IIIDirector · President and CEO
GrantCommon Stock 69,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015792 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132,517

F2 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:03 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 1,132 $25.91 $29,330.12
Disclosure

SEC source: 0001209191-22-015792 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,062,817

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
February 18, 2022 Filed Feb 22, 2022 22:45 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 3,939 $27.13 $106,865.07
Disclosure

SEC source: 0001209191-22-011844 · doc4.xml · nonDerivative · entry 3

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,063,949

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 18, 2022 Filed Feb 22, 2022 22:45 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 8,561 $26.81 $229,520.41
Disclosure

SEC source: 0001209191-22-011844 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,067,888

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.01 to $27.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 22:45 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 12,500 $27.22 $340,250.00
Disclosure

SEC source: 0001209191-22-011844 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,076,449

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.87 to $27.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 21, 2022 Filed Jan 24, 2022 22:41 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 200 $24.73 $4,946.00
Disclosure

SEC source: 0001209191-22-004643 · doc4.xml · nonDerivative · entry 4

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,088,949

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
January 21, 2022 Filed Jan 24, 2022 22:41 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 187 $24.72 $4,622.64
Disclosure

SEC source: 0001209191-22-004643 · doc4.xml · nonDerivative · entry 3

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,089,149

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
January 21, 2022 Filed Jan 24, 2022 22:41 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 12,113 $24.22 $293,376.86
Disclosure

SEC source: 0001209191-22-004643 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,089,336

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:41 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 12,500 $25.98 $324,750.00
Disclosure

SEC source: 0001209191-22-004643 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101,449

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.33 to $26.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 16, 2021 Filed Dec 18, 2021 01:06 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 6,598 $31.91 $210,542.18
Disclosure

SEC source: 0001209191-21-070463 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,113,949

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.46 to $32.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 16, 2021 Filed Dec 18, 2021 01:06 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 18,402 $30.74 $565,677.48
Disclosure

SEC source: 0001209191-21-070463 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,120,547

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.43 to $31.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 22:48 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 24 $31.58 $757.92
Disclosure

SEC source: 0001209191-21-070035 · doc4.xml · nonDerivative · entry 3

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,420

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 22:48 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 2,976 $30.52 $90,827.52
Disclosure

SEC source: 0001209191-21-070035 · doc4.xml · nonDerivative · entry 2

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,444

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.36 to $31.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 23:22 UTC
Rose Geoffrey BeranChief Commercial Officer
SaleCommon Stock 360 $31.48 $11,332.80
Disclosure

SEC source: 0001209191-21-070066 · doc4.xml · nonDerivative · entry 2

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,459

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.36 to $31.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 23:22 UTC
Rose Geoffrey BeranChief Commercial Officer
SaleCommon Stock 21,640 $30.53 $660,669.20
Disclosure

SEC source: 0001209191-21-070066 · doc4.xml · nonDerivative · entry 1

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,819

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.335 to $31.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 14, 2021 Filed Dec 16, 2021 22:48 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 3,000 $32.89 $98,670.00
Disclosure

SEC source: 0001209191-21-070035 · doc4.xml · nonDerivative · entry 1

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,420

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.39 to $33.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 01, 2021 Filed Dec 4, 2021 00:11 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 1,421 $32.73 $46,509.33
Disclosure

SEC source: 0001209191-21-067999 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,138,949

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 23:41 UTC
Lehman David AaronGeneral Counsel
SaleCommon Stock 383 $32.73 $12,535.59
Disclosure

SEC source: 0001209191-21-067972 · doc4.xml · nonDerivative · entry 1

Lehman David Aaron · CIK 0001354228 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,834

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 23:39 UTC
Rose Geoffrey BeranChief Commercial Officer
SaleCommon Stock 355 $32.73 $11,619.15
Disclosure

SEC source: 0001209191-21-067971 · doc4.xml · nonDerivative · entry 1

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,459

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 23:34 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 383 $32.73 $12,535.59
Disclosure

SEC source: 0001209191-21-067970 · doc4.xml · nonDerivative · entry 1

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,420

F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 23:44 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 100 $37.09 $3,709.00
Disclosure

SEC source: 0001209191-21-066199 · doc4.xml · nonDerivative · entry 4

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105,370

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 23:44 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 100 $37.08 $3,708.00
Disclosure

SEC source: 0001209191-21-066199 · doc4.xml · nonDerivative · entry 3

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105,470

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 23:44 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 13,209 $36.47 $481,732.23
Disclosure

SEC source: 0001209191-21-066199 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105,570

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.06 to $37.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 23:44 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 11,591 $35.40 $410,321.40
Disclosure

SEC source: 0001209191-21-066199 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,118,779

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2021 Filed Nov 16, 2021 23:09 UTC
Rose Geoffrey BeranChief Commercial Officer
SaleCommon Stock 7,000 $39.94 $279,580.00
Disclosure

SEC source: 0001209191-21-064854 · doc4.xml · nonDerivative · entry 1

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,814

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.83 to $40.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 21, 2021 Filed Oct 22, 2021 23:11 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 8,597 $39.99 $343,794.03
Disclosure

SEC source: 0001209191-21-061431 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,130,370

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 21, 2021 Filed Oct 22, 2021 23:11 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 16,403 $39.62 $649,886.86
Disclosure

SEC source: 0001209191-21-061431 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,138,967

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.73 to $39.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 15, 2021 Filed Oct 19, 2021 00:09 UTC
Rose Geoffrey BeranChief Commercial Officer
SaleCommon Stock 7,000 $39.44 $276,080.00
Disclosure

SEC source: 0001209191-21-060779 · doc4.xml · nonDerivative · entry 1

Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,814

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.001 to $40.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 21, 2021 Filed Sep 22, 2021 00:11 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 3,000 $37.50 $112,500.00
Disclosure

SEC source: 0001209191-21-057147 · doc4.xml · nonDerivative · entry 3

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,803

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020, as amended August 20, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.30 to $37.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 20, 2021 Filed Sep 21, 2021 00:45 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 1,700 $38.01 $64,617.00
Disclosure

SEC source: 0001209191-21-056974 · doc4.xml · nonDerivative · entry 3

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020, as amended August 20, 2021.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.875 to $38.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.

Read SEC document
September 20, 2021 Filed Sep 21, 2021 00:45 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 21,871 $37.31 $816,007.01
Disclosure

SEC source: 0001209191-21-056974 · doc4.xml · nonDerivative · entry 2

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,700

F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020, as amended August 20, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.81 to $37.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 00:11 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 115 $37.96 $4,365.40
Disclosure

SEC source: 0001209191-21-057147 · doc4.xml · nonDerivative · entry 2

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,803

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020, as amended August 20, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.86 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 00:11 UTC
Sung DerrickChief Financial Officer
SaleCommon Stock 2,885 $37.33 $107,697.05
Disclosure

SEC source: 0001209191-21-057147 · doc4.xml · nonDerivative · entry 1

Sung Derrick · CIK 0001670118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,918

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020, as amended August 20, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.81 to $37.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2021 Filed Sep 21, 2021 00:45 UTC
French Glendon E. IIIDirector · President and CEO
SaleCommon Stock 25,000 $38.86 $971,500.00
Disclosure

SEC source: 0001209191-21-056974 · doc4.xml · nonDerivative · entry 1

French Glendon E. III · CIK 0001805624 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,155,370

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.26 to $39.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.